Clear Lensectomy with Hydrus Stent in Black and Afro-Latino Patients: A 1-Year Retrospective Study

Daniel Laroche; Jessinta Oseni; Gideon Nkrumah; Chester Ng

doi:10.1155/2022/8011745

Clear Lensectomy with Hydrus Stent in Black and Afro-Latino Patients: A 1-Year Retrospective Study

J Ophthalmol. 2022 Aug 31:2022:8011745. doi: 10.1155/2022/8011745. eCollection 2022.

Authors

Daniel Laroche^{1

2}, Jessinta Oseni³, Gideon Nkrumah⁴, Chester Ng²

Affiliations

¹ Department of Ophthalmology, Icahn School of Medicine at Mount Sinai and New York Eye and Ear of Mount Sinai, New York, New York, USA.
² Advanced Eyecare of New York, New York, New York, USA.
³ Albert Einstein College of Medicine, Bronx, New York, USA.
⁴ University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Abstract

Purpose: To determine the efficacy and safety of phacoemulsification, clear lensectomy, and the Hydrus microstent (Ivantis, Inc.) in Black and Afro-Latino glaucoma patients.

Method: This is a retrospective nonrandomized study of 134 Black and Afro-Latino patients who underwent clear lensectomy with Hydrus stent implant for the treatment of glaucoma. For comprehensive analysis, patients were divided into mild, moderate, and advanced glaucoma. The evaluated parameters were reductions in the number of medications, intraocular pressure (IOP), mean deviation on visual field test, and visual acuity.

Results: A total of 134 patients with 1-year follow-up were evaluated. At 1 year, the average number of medications significantly decreased from 2.5 ± 1.4 preoperatively to 0.43 ± 1.04 (p < 0.001) and IOP decreased from 14.4 ± 3.9 to 13.8 ± 3.10 (p=0.16). 110 (82.1%) patients were medication-free at 1 year (n = 57, 83.8% mild glaucoma; n = 37, 92.5% moderate glaucoma; n = 16, 61.5% advanced glaucoma). There was stabilization of mean deviation on the visual field test (baseline, -8.28; 1 year, -8.28; p=1). The most reported adverse effects were transient IOP spike and hyphema (n = 7, 5.2%; n = 3, 2.2%, respectively); both events were self-resolving. No decline in vision or sight-threatening complications were reported at 1 year, and no additional surgeries were required.

Conclusion: This 1-year retrospective study demonstrated the efficacy and safety of clear lensectomy and Hydrus stent implantation in decreasing medication burden while maintaining lower IOP in Black and Afro-Latino glaucoma patients.